These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 6979979)

  • 21. Circulating immune complexes and complement in rheumatoid arthritis.
    Duquesnoy B
    Ann Biol Clin (Paris); 1984; 42(1):71-5. PubMed ID: 6375473
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of immune complexes and complement components in arterial and venous blood of patients with rheumatoid arthritis.
    Steven MM; Westedt ML; Daha MR; de Vries E; Cats A
    J Rheumatol; 1986 Feb; 13(1):74-8. PubMed ID: 3701744
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Circulating immune complexes-like material and complement in rheumatoid arthritis and ankylosing spondylitis (author's transl)].
    Rodrigo MJ; Gallart MT; Lience E; Arnal C; Sans J
    Med Clin (Barc); 1981 Apr; 76(8):339-46. PubMed ID: 6789016
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiperinuclear factor and keratin antibodies in rheumatoid arthritis.
    Johnson GD; Carvalho A; Holborow EJ; Goddard DH; Russell G
    Ann Rheum Dis; 1981 Jun; 40(3):263-6. PubMed ID: 6166255
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of therapy on the neutropenia of hyperthyroidism.
    Eakin DL; Peake RL; Weiss GB
    South Med J; 1983 Mar; 76(3):335-7, 340. PubMed ID: 6828901
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Serum complement levels in patients with rheumatoid arthritis and vasculitis].
    Tomooka K
    Fukuoka Igaku Zasshi; 1989 Oct; 80(10):456-66. PubMed ID: 2613159
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neutropenia, splenomegaly and high titre antinuclear antibody.
    Linch DC
    J R Soc Med; 1978 Feb; 71(2):143-4. PubMed ID: 305480
    [No Abstract]   [Full Text] [Related]  

  • 28. Management of neutropenia in patients with rheumatoid arthritis.
    Lazaro E; Morel J
    Joint Bone Spine; 2015 Jul; 82(4):235-9. PubMed ID: 25819216
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Liver disease in rheumatoid arthritis and Sjøgren's syndrome. Prospective study using biochemical and serological markers of hepatic dysfunction.
    Webb J; Whaley K; MacSween RN; Nuki G; Dick WC; Buchanan WW
    Ann Rheum Dis; 1975 Feb; 34(1):70-81. PubMed ID: 1092275
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IgG rheumatoid factors and anti-nuclear antibodies in rheumatoid vasculitis.
    Quismorio FP; Beardmore T; Kaufman RL; Mongan ES
    Clin Exp Immunol; 1983 May; 52(2):333-40. PubMed ID: 6602676
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection and characterization of circulating immune complexes in rheumatoid arthritis.
    Wattre P; Santoro F; Bout D; Defrance D; Capron A
    Biomedicine; 1976 Sep; 25(7):249-51. PubMed ID: 990384
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Suppressor cell-mediated neutropenia in Felty's syndrome.
    Abdou NI; NaPombejara C; Balentine L; Abdou NL
    J Clin Invest; 1978 Mar; 61(3):738-43. PubMed ID: 305925
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased frequency and specific reactivity of serum antinuclear antibodies in patients with nonimmune chronic idiopathic neutropenia of adults.
    Papadaki HA; Psyllaki M; Eliopoulos DG; Tsiroyianni A; Eliopoulos GD
    Acta Haematol; 2001; 105(1):13-20. PubMed ID: 11340248
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Granulopoietic activity in Felty's syndrome.
    Gupta R; Robinson WA; Albrecht D
    Ann Rheum Dis; 1975 Apr; 34(2):156-61. PubMed ID: 49177
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitation and characterization of soluble immune complexes precipitated from sera by polyethylene glycol (PEG).
    Chia D; Barnett EV; Yamagata J; Knutson D; Restivo C; Furst D
    Clin Exp Immunol; 1979 Sep; 37(3):399-407. PubMed ID: 315842
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circulating and tissue immune complexes in leprosy.
    Sehgal S; Kumar B
    Int J Lepr Other Mycobact Dis; 1981 Sep; 49(3):294-301. PubMed ID: 6976333
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circulating complement breakdown products in patients with rheumatoid arthritis. Correlation between plasma C3d, circulating immune complexes, and clinical activity.
    Nydegger UE; Zubler RH; Gabay R; Joliat G; Karagevrekis CH; Lambert PH; Miescher PA
    J Clin Invest; 1977 May; 59(5):862-8. PubMed ID: 853126
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immune-complexes (IC) in idiopathic neutropenia.
    Cappio FC; Camussi G; Novarino A; Campana D; Masera C; Infelise V; Gavosto F
    Scand J Haematol; 1981 Nov; 27(5):311-22. PubMed ID: 7051264
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Felty's syndrome: an analytical review.
    Spivak JL
    Johns Hopkins Med J; 1977 Sep; 141(3):156-62. PubMed ID: 330914
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparative study of complement components in polyethylene glycol precipitated immune complexes from patients with ovarian cancer and patients with rheumatoid arthritis.
    Mooney NA; Hay FC; Poulton TA
    Clin Exp Immunol; 1983 Jun; 52(3):561-8. PubMed ID: 6603297
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.